Table 1.
Distribution by sample origin of STs with ≥20 isolates in the study period (1990 to 2008)
| ST no. | No. of isolates (%)e |
|||
|---|---|---|---|---|
| CSF | PPE | Blood | Totala | |
| 81 | 6 (11.1) | 0 (0.0) | 14 (3.4) | 20 (3.9) |
| 193 | 5 (9.2) | 0 (0.0) | 19 (4.6) | 24 (4.7) |
| 199 | 1 (1.9) | 0 (0.0) | 19 (4.6) | 20 (3.9) |
| 202 | 2 (3.7) | 5 (12.2) | 44 (10.7) | 51 (9.9) |
| 276 | 7 (13.0) | 9 (22.0) | 35 (8.5) | 51 (9.9) |
| 320 | 1 (1.9) | 5 (12.2) | 15 (3.7) | 23b (4.5) |
| 878 | 7 (13.0) | 7 (17.1) | 31 (7.6) | 46c (8.9) |
| 1201 | 7 (13.0) | 4 (9.7) | 86 (20.9) | 97 (18.9) |
| 2108 | 3 (5.5) | 1 (2.4) | 17 (4.1) | 21 (4.1) |
| Other STs | 15 (27.7) | 10 (24.4) | 131 (31.9) | 161d (31.3) |
| Total | 54 (100) | 41 (100) | 411 (100) | 514a (100) |
a
Includes 8 isolates from other samples: 5 joint fluid, 2 peritoneal fluid, and 1 biopsy samples.
b
Includes 2 isolates from 2 joint fluid samples.
c
Includes 1 isolate from peritoneal fluid sample.
d
Includes 5 isolates from other samples: 3 joint fluid, 1 peritoneal fluid, and 1 biopsy sample.
e
CSF, cerebrospinal fluid; PPE, pediatric parapneumonic empyema.